Chronic Lymphocytic Leukemia

Click here for RSS
Latest News
Recent success with novel agents for chronic lymphocytic leukemia has spurred development of more agents in the same therapeutic classes; however, definitive advantages over the originals have yet to be established. Read More >>
View Free CME from PER
top border
top border
Featured Programs

New Agents in Chronic Lymphocytic Leukemia: A Practical Guide
This expert panel discussion led by William Wierda, MD, focuses on new agents available for the treatment of chronic lymphocytic leukemia.

Dr Wierda is joined in this discussion by Alessandro Ferrajoli, MD; Richard R. Furman, MD; Thomas J. Kipps, MD, PhD; Shuo Ma, MD, PhD; and Susan M. O'Brien, MD. The panelists share their experiences in treating patients with CLL, including prognostic factors, use of chemoimmunotherapy, and the potential for newer agents that are now available or being studied.

View Now

Initiating Therapy for Chronic Lymphocytic Leukemia
In this segment William Wierda, MD, PhD, and Jennifer Brown, MD, PhD, discuss the triggers for starting therapy in a patient who has chronic lymphocytic leukemia.

View Now

Immunotherapy and Oncology

Anti-Angiogenic Therapy in Lung and GI Cancers

Anti-Angiogenic Therapy in Lung and GI Cancers
Mark Socinski, MD, moderates this OncLive Peer Exchange panel discussion on modern use of anti-angiogenic therapy. The experts in gastrointestinal and lung cancers include Johanna C. Bendell, MD; Edward Garon, MD; Roy Herbst, MD; Yelena Y. Janjigian, MD; and Manish Shah, MD.
View Now
Vincent T. DeVita Jr MD
In The Death of Cancer, written by Vincent T. DeVita Jr, MD, a pioneering oncologist reveals, after 50 years on the front lines of medicine, why the war on cancer is winnable, and how to get there.
Publication Bottom Border
Border Publication